Chemistry and molecular aspects of drug design and action. (©2008)
- Record Type:
- Book
- Title:
- Chemistry and molecular aspects of drug design and action. (©2008)
- Main Title:
- Chemistry and molecular aspects of drug design and action
- Further Information:
- Note: Editors, E.A. Rekka and P.N. Kourounakis.
- Other Names:
- Rekka, E. A
Kourounakis, P. N - Contents:
- Inflammatory mechanisms in Alzheimer's disease and other neurodegenerative disorders / J. Rogers [and others] -- Treatment development strategies for Alzheimer's disease / E. Wülfert -- Lipoprotein-associated phospholipase A2 as a new prognostic factor for coronary artery disease / A. Tselepis -- Protein modifications by nitric oxide and reactive nitrogen species / H. Ischiropoulos -- Design, synthesis, and pharmacological evaluation of high affinity and selectivity sigma-1 and sigma-2 receptor ligands / J.H. Poupaert -- Synthesis of biologically active taxoids / K.C. Nicolaou and R.K. Guy -- From the molecular pharmacology to the medicinal chemistry of cannabinoids / D.M. Lambert -- New inhibitors of DNA topoisomerase in the treatment of experimental malignancies / C. Atassi -- Treatment of psoriasis with anthrones-biochemical aspects / W. Wiegrebe and K. Müller -- An appraisal of fomocaines, current situation, and outlook / H. Oelschläger and A. Seeling -- Ligands for the GABA recognition site at the GABAA receptor: structure-activity studies / B. Frølund [and others] -- Discovery of potent and selective inhibitors of human aldosterone synthase (CYP11B2): a new target for the treatment of congestive heart failure and myocardial fibrosis: a review / R.W. Hartmann [and others]. Thiocarboxanilides: a new class of non-nucleoside reverse transcriptase inhibitors (NNRTIS) with great potential for the treatment of human immunodeficiency virus type 1 (HIV-1) infections / E. DeInflammatory mechanisms in Alzheimer's disease and other neurodegenerative disorders / J. Rogers [and others] -- Treatment development strategies for Alzheimer's disease / E. Wülfert -- Lipoprotein-associated phospholipase A2 as a new prognostic factor for coronary artery disease / A. Tselepis -- Protein modifications by nitric oxide and reactive nitrogen species / H. Ischiropoulos -- Design, synthesis, and pharmacological evaluation of high affinity and selectivity sigma-1 and sigma-2 receptor ligands / J.H. Poupaert -- Synthesis of biologically active taxoids / K.C. Nicolaou and R.K. Guy -- From the molecular pharmacology to the medicinal chemistry of cannabinoids / D.M. Lambert -- New inhibitors of DNA topoisomerase in the treatment of experimental malignancies / C. Atassi -- Treatment of psoriasis with anthrones-biochemical aspects / W. Wiegrebe and K. Müller -- An appraisal of fomocaines, current situation, and outlook / H. Oelschläger and A. Seeling -- Ligands for the GABA recognition site at the GABAA receptor: structure-activity studies / B. Frølund [and others] -- Discovery of potent and selective inhibitors of human aldosterone synthase (CYP11B2): a new target for the treatment of congestive heart failure and myocardial fibrosis: a review / R.W. Hartmann [and others]. Thiocarboxanilides: a new class of non-nucleoside reverse transcriptase inhibitors (NNRTIS) with great potential for the treatment of human immunodeficiency virus type 1 (HIV-1) infections / E. De Clercq, A. Karlsson, and J. Balzarini -- Histamine H3-receptor agonists and antagonists: chemical, pharmacological, and clinical aspects / H. Stark and W. Schunack -- Anti-inflammatory actions of flavonoids and structural requirements / T. Theoharides -- Molecular mechanisms of H2O2-induced DNA damage: the action of desferrioxamine / M. Tenopoulou, P.-T Doulias, and D. Galaris -- LNA (locked nucleic acid) and functionalized LNA: towards efficient gene targeting / J. Wengel -- The effect of diet on drug metabolism / K.J. Netter -- Cytochromes P450 in the metabolism and bioactivation of chemicals / C. Ioannides -- In vitro methods to measure drug metabolism and metabolic interactions in drug discovery and development / O. Pelkonen [and others] -- How to probe the sites of action of drug molecules / A. Makriyannis and F. Bitter -- Lipophilicity as a descriptor of molecular properties in drug design / B. Testa [and others] -- Drug membrane interaction and the importance for drug transport, distribution, accumulation, efficacy, and resistance / J.K. Seydel [and others] -- Structure-based and computer-aided drug design / H. Kubinyi -- Physicochemical profiling in early drug discovery: new challenges at the age of high-throughput screen and combinatorial chemistry / B. Faller. … (more)
- Publisher Details:
- Boca Raton : Taylor & Francis
- Publication Date:
- 2008
- Copyright Date:
- 2008
- Extent:
- 1 online resource
- Subjects:
- 615/.19
Pharmaceutical chemistry
Drugs -- Design
Chemistry, Pharmaceutical
Drug Design
Pharmacologic Actions
Pharmaceutical industry
MEDICAL -- Drug Guides
MEDICAL -- Pharmacology
MEDICAL -- Pharmacy
MEDICAL -- Nursing -- Pharmacology
Drugs -- Design
Pharmaceutical chemistry
Electronic books - Languages:
- English
- ISBNs:
- 9781420008272
1420008277
1281274437
9781281274434 - Related ISBNs:
- 9780849390067
0849390060 - Notes:
- Note: Includes bibliographical references and index.
Note: Print version record. - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.149457
- Ingest File:
- 01_032.xml